Cytotoxic T cells with reciprocal antigenic peptide presentation function are not generally resistant to mutual lysis

Immunology and Cell Biology

Volumn 81, Issue 4, 2003, Pages 266-274

  Staege, Martin S ^a,b   Gisch, Karina ^a   Reske Kunz, Angelika B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cytotoxic T cells; Reciprocal antigen presentation; Reciprocal lysis

Indexed keywords

INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ACCESSORY CELL; ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; IMMUNOSTIMULATION; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; T LYMPHOCYTE; TARGET CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; CELL SURVIVAL; CLONE CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FLOW CYTOMETRY; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; OVALBUMIN; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

ANIMALIA; MURINAE;

EID: 0042347803     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2003.t01-1-01164.x     Document Type: Article

References (46)

1. Rammensee HG, Falk K, Rötzschke O. Peptides naturally presented by MHC class I molecules. Ann. Rev. Immunol. 1993; 11: 213-44.
2. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Ann. Rev. Immunol. 1989; 7: 601-24.
3. Pichler WJ, Wyss-Coray T. T cells as antigen-presenting cells. Immunol. Today 1994; 15: 312-15.
4. Dick T, Reske-Kunz AB. Major histocompatibility complex class I restricted activation of cloned T cells by a soluble protein in the absence of accessory cells. Proc. Natl Acad. Sci. USA 1989; 86: 2316-20.
5. Staege MS, Dick T, Ertl R et al. The antigen self-presentation function of the cytotoxic T-cell clone 10BK.1 depends on reciprocal peptide presentation. Immunology 1994; 83: 333-7.
6. Dick T, Staege MS, Reichmann G, Reske-Kunz AB. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen. J. Immunol. 1993; 150: 2575-83.
7. Staege MS, Holtappels R, Thomas D, Reddehase MJ, Reske-Kunz AB. Proliferation and MHC-unrestricted bystander lysis of cytotoxic T-cells following antigen self-presentation. Med. Microbiol. Immunol. (Berl.) 1998; 187: 17-21.
8. Staege MS, Schneider J, Eulitz M et al. Consequences of antigen self-presentation by tumour-specific cytotoxic T cells. Immunobiol. 2000; 201: 332-46.
9. Dionne SO, Smith MH, Marincola FM, Lake DF. Antigen presentation of a modified tumor-derived peptide by tumor infiltrating lymphocytes. Cell. Immunol. 2002; 214: 139-44.
10. Steven NM, Leese AM, Annels NE, Lee SP, Rickinson AB. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J. Exp. Med. 1996; 184: 1801-13.
11. Butz EA, Bevan MJ. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 1998; 8: 167-75.
12. + T cells to lysis by cytotoxic granules from cloned T cell lines. Int. Immunol. 1990; 2: 99-103.
13. Ojcius DM, Jiang S, Persechini PM, Detmers PA, Young DE. Cytoplasts from cytotoxic T lymphocytes are resistant to perforin mediated lysis. Mol. Immunol. 1991; 28: 1011-18.
14. Burrows SR, Suhrbier A, Khanna R, Moss DJ. Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing. Immunology 1992; 76: 174-5.
15. Dutz JP, Walden PR, Eisen HN. Effects of cognate peptides on cytolytic and proliferative activities of cloned cytotoxic T lymphocytes. Int. Immunol. 1992; 4: 571-80.
16. Pemberton RM, Wraith DC, Askonas BA. Influenza peptide-induced self-lysis and down-regulation of cloned cytotoxic T cells. Immunol. 1990; 70: 223-9.
17. Ackermann B, Staege MS, Reske-Kunz AB, Dienes HP, Meyer zum Büschenfelde KH, Märker-Hermann E. Enterobacteria infected T cells as antigen presenting cells for cytotoxic CD8 T cells: a contribution to the self-limitation of cellular immune reactions in reactive arthritis? J. Infect. Dis. 1997; 175: 1121-7.
18. Vignaux F, Golstein P. Fas-based lymphocyte-mediated cytotoxicity against activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 1994; 24: 923-7.
19. Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype. Cell. Immunol. 1997; 181: 93-100.
20. Janssen O, Sanzenbacher R, Kabelitz D. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res. 2000; 301: 85-99.
21. Zheng L, Trageser CL, Willerford DM, Lenardo MJ. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J. Immunol. 1998; 160: 763-9.
22. Dick T, Reichmann G, Ebnet K et al. An ovalbumin peptide-specific cytotoxic T cell clone with antigen self-presentation capacity uses two distinct mechanisms to kill target cells. Cell. Immunol. 1993; 152: 333-47.
23. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988; 54: 777-85.
24. Fischer HG, Opel B, Reske K, Reske-Kunz AB. Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli. Eur. J. Immunol. 1988; 18: 1151-8.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 1983; 65: 55-63.
26. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor / tumor necrosis factor from human monocytes. J. Immunol. Meth. 1986; 95: 99-105.
27. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986; 136: 2348-57.
28. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 1992; 127: 5-24.
29. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated CD95-mediated T cell apoptosis. Immunity 1998; 8: 615-23.
30. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and CD95 lytic pathways. Nature 1994; 370: 650-2.
31. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J. Cytotoxic T cells deficient in both functional CD95 ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 1996; 183: 657-61.
32. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-activation. Cell 1995; 81: 495-504.
33. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995; 377: 348-51.
34. Grell M, Scheurich P. Tumour necrosis factor. In: Le Roith D, Bondy C, eds. Growth Factors and Cytokines in Health and Disease, Vol. 2B. Greenwich: JAI Press Inc, 1997; 669-726.
35. Davidson WF, Haudenschild C, Kwon J, Williams MS. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent. J. Immunol. 2002; 169: 6218-30.
36. Burrows SR, Fernan A, Argaet V, Suhrbier A. Bystander apoptosis induced by CD8+ cytotoxic T cell (CTL) clones: implications for CTL lytic mechanisms. Int. Immunol. 1993; 5: 1049-58.
37. Suhrbier A, Burrows SR, Fernan A, Lavan MF, Baxter GD, Moss DJ. Peptide epitope induced apoptosis of human cytotoxic T lymphocytes: Implications for peripheral T cell deletion and peptide vaccination. J. Immunol. 1993; 150: 2169-78.
38. Staege MS, Gorelov V, Bulankin A et al. Stable transgenic expression of IL-2 and HSV1-tk by single and fusion tumor cell lines bearing EWS/FLI-1 chimeric genes. Pediatr. Hematol. Oncol. 2003; 20: 119-40.
39. Beadling C, Smith KA. DNA array analysis of interleukin-2-regulated immediate/early genes. Med. Immunol. 2002; 1: 2.
40. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993; 361: 359-62.
41. Widmann C, Maryanski JL, Romero P, Corradin G. Differential stability of antigenic MHC class I-restricted synthetic peptides. J. Immunol. 1991; 147: 3745-51.
42. Carbone FR, Bevan MJ. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 1989; 169: 603-12.
43. Carbone FR, Moore MW, Sheil JM, Bevan MJ. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. J. Exp. Med. 1988; 167: 1767-79.
44. Ishioka GY, Colon S, Miles C, Grey HM, Chesnut RW. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo. J. Immunol. 1989; 143: 1094-100.
45. Sambhara SR, Upadhya AG, Miller RG. Generation and characterization of peptide-specific, MHC-restricted cytotoxic T lymphocyte (CTL) and helper T cell lines from unprimed T cells under microculture conditions. J. Immunol. Methods 1990; 130: 101-9.
46. Aichele P, Brduscha-Riem K, Zinkernagel RM, Hengartner H, Pitcher HJ. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med. 1995; 182: 261-6.